共 27 条
[1]
Anderson T.D., Hayes T.J., Toxicity of human recombinant interleukin-2 in rats. Pathologic changes are characterized by marked lymphocytic and eosinophilic proliferation and multisystem involvement, Lab. Invest, 60, pp. 331-346, (1989)
[2]
Aronson F.R., Libby P., Brandon E.P., Janicka M.W., Mier J.W., IL-2 rapidly induces natural killer cell adhesion to human endothelial cells. A potential mechanism for endothelial injury, J. Immunol, 141, pp. 158-163, (1988)
[3]
Blay J.Y., Bertoglio J., Fradelizi D., Chouaib S., Functional interactions of IL-2 and TNF in the differentiation of LGL into LAK effectors, Int. J. Cancer, 44, pp. 598-604, (1989)
[4]
Chang A.E., Hyatt C.L., Rosenberg S.A., Systemic administration of recombinant human interleukin-2 in mice, J. Biol. Response Mod, 3, pp. 561-572, (1984)
[5]
Curran R.D., Billiar T.R., West M.A., Bentz B.G., Simmons R.L., Effect of interleukin-2 on Kupffer cell activation. Interleukin-2 primes and activates Kupffer cells to suppress hepatocyte protein synthesis in vitro, Arch. Surg, 123, pp. 1373-1378, (1988)
[6]
Decker K., Review: Biologically active products of stimulated liver macrophages (Kupffer cells), Eur. J. Biochem, 192, pp. 245-261, (1990)
[7]
Decker T., Lohmann-Matthes M.L., Karck U., Peters T., Decker K., Comparative study of cytotoxicity, tumor necrosis factor, and prostaglandin release after stimulation of rat Kupffer cells, murine Kupffer cells, and murine inflammatory liver macrophages, J. Leukoc. Biol, 45, pp. 139-146, (1989)
[8]
Economou J.S., McBride W.H., Essner R., Rhoades K., Golub S., Holmes E.C., Morton D.L., Tumour necrosis factor production by IL-2 activated macrophages in vitro and in vivo, Immunology, 67, pp. 514-519, (1989)
[9]
Gaillard T., Mulsch A., Busse R., Klein H., Decker K., Regulation of nitric oxide production by stimulated rat Kupffer cells, Pathobiology, 59, pp. 280-283, (1991)
[10]
Goodwin J.S., Webb D.R., Regulation of the immune response by prostaglandins, Clin. Immunol. Immunopathol, 15, pp. 106-122, (1980)